Abstract Extensive molecular analyses by many groups have revealed a heterogenous landscape of embryonal brain tumors, but patient-derived tumor organoid (TO) model development has remained limited. Here, we describe the establishment of TO and TO xenografts (TOX) from patient-derived orthotopic xenografts (PDOXs) of medulloblastoma, embryonal tumor with multilayer rosettes, and atypical teratoid rhabdoid tumors.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jose
Contact Jose, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack